Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2022 Jul 18

PMID 35844605

Authors

Jing Gao

Yuanzheng Liang

Liang Wang

Affiliations

Soon will be listed here.

Abstract

Different stimuli can polarize macrophages into two basic types, M1 and M2. Tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) are composed of heterogeneous subpopulations, which include the M1 anti-tumor and M2 pro-tumor phenotypes. TAMs predominantly play a M2-like tumor-promoting role in the TME and regulate various malignant effects, such as angiogenesis, immune suppression, and tumor metastasis; hence, TAMs have emerged as a hot topic of research in cancer therapy. This review focuses on three main aspects of TAMs. First, we summarize macrophage polarization along with the effects on the TME. Second, recent advances and challenges in cancer treatment and the role of M2-like TAMs in immune checkpoint blockade and CAR-T cell therapy are emphasized. Finally, factors, such as signaling pathways, associated with TAM polarization and potential strategies for targeting TAM repolarization to the M1 pro-inflammatory phenotype for cancer therapy are discussed.

Citing Articles

The role of tumor-associated macrophages in lung cancer.

Zhu R, Huang J, Qian F Front Immunol. 2025; 16:1556209.

PMID: 40079009 PMC: 11897577. DOI: 10.3389/fimmu.2025.1556209.

Bacterial-Mediated In Situ Engineering of Tumour-Associated Macrophages for Cancer Immunotherapy.

Kuhl G, Tangney M Cancers (Basel). 2025; 17(5).

PMID: 40075571 PMC: 11899205. DOI: 10.3390/cancers17050723.

Integrated multiomics analysis and machine learning refine neutrophil extracellular trap-related molecular subtypes and prognostic models for acute myeloid leukemia.

Zhong F, Yao F, Wang Z, Liu J, Huang B, Wang X Front Immunol. 2025; 16:1558496.

PMID: 40066454 PMC: 11891243. DOI: 10.3389/fimmu.2025.1558496.

Comprehensive immunophenotyping reveals distinct tumor microenvironment alterations in anti-PD-1 sensitive and resistant syngeneic mouse model.

Inoue H, Hamasaki T, Inoue K, Nakao A, Ebi N, Minomo H Sci Rep. 2025; 15(1):8311.

PMID: 40064915 PMC: 11894063. DOI: 10.1038/s41598-025-91979-w.

Unmasking the potential: mechanisms of neuroinflammatory modulation by oncolytic viruses in glioblastoma.

Beder N, Mirbahari S, Belkhelfa M, Mahdizadeh H, Totonchi M Explor Target Antitumor Ther. 2025; 6:1002294.

PMID: 40061139 PMC: 11886384. DOI: 10.37349/etat.2025.1002294.

References

Jia X, Yu F, Wang J, Iwanowycz S, Saaoud F, Wang Y . Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs. Breast Cancer Res Treat. 2014; 148(2):291-302. PMC: 4224983. DOI: 10.1007/s10549-014-3164-7. View

Xiao M, Zhang J, Chen W, Chen W . M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma. J Exp Clin Cancer Res. 2018; 37(1):143. PMC: 6038304. DOI: 10.1186/s13046-018-0815-2. View

Sa J, Chang N, Lee H, Cho H, Ceccarelli M, Cerulo L . Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma. Genome Biol. 2020; 21(1):216. PMC: 7448990. DOI: 10.1186/s13059-020-02140-x. View

Fang W, Zhou T, Shi H, Yao M, Zhang D, Qian H . Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8 T cell exclusion. J Exp Clin Cancer Res. 2021; 40(1):4. PMC: 7780622. DOI: 10.1186/s13046-020-01786-6. View

Zhu M, Liu W, Wang H, Wang W, Liu N, Lu Y . NSE from diffuse large B-cell lymphoma cells regulates macrophage polarization. Cancer Manag Res. 2019; 11:4577-4595. PMC: 6529732. DOI: 10.2147/CMAR.S203010. View

Benoit M, Desnues B, Mege J . Macrophage polarization in bacterial infections. J Immunol. 2008; 181(6):3733-9. DOI: 10.4049/jimmunol.181.6.3733. View

Lizotte P, Baird J, Stevens C, Lauer P, Green W, Brockstedt D . Attenuated reprograms M2-polarized tumor-associated macrophages in ovarian cancer leading to iNOS-mediated tumor cell lysis. Oncoimmunology. 2014; 3:e28926. PMC: 4106169. DOI: 10.4161/onci.28926. View

Santoni M, Massari F, Montironi R, Battelli N . Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophages. Biochim Biophys Acta Rev Cancer. 2021; 1876(1):188547. DOI: 10.1016/j.bbcan.2021.188547. View

Nakao S, Kuwano T, Tsutsumi-Miyahara C, Ueda S, Kimura Y, Hamano S . Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. J Clin Invest. 2005; 115(11):2979-91. PMC: 1257532. DOI: 10.1172/JCI23298. View

10.

Shu Y, Cheng P . Targeting tumor-associated macrophages for cancer immunotherapy. Biochim Biophys Acta Rev Cancer. 2020; 1874(2):188434. DOI: 10.1016/j.bbcan.2020.188434. View

11.

Wei B, Pan J, Yuan R, Shao B, Wang Y, Guo X . Polarization of Tumor-Associated Macrophages by Nanoparticle-Loaded Combined with Immunogenic Cell Death for Cancer Immunotherapy. Nano Lett. 2021; 21(10):4231-4240. DOI: 10.1021/acs.nanolett.1c00209. View

12.

Kim S, Saeidi S, Zhong X, Gwak S, Muna I, Park S . Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages. Neoplasia. 2020; 22(11):606-616. PMC: 7581991. DOI: 10.1016/j.neo.2020.08.006. View

13.

Wu H, Zhang X, Han D, Cao J, Tian J . Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8. PeerJ. 2020; 8:e8721. PMC: 7073239. DOI: 10.7717/peerj.8721. View

14.

Shao J, Zaro J, Shen Y . Advances in Exosome-Based Drug Delivery and Tumor Targeting: From Tissue Distribution to Intracellular Fate. Int J Nanomedicine. 2020; 15:9355-9371. PMC: 7700079. DOI: 10.2147/IJN.S281890. View

15.

Sylvestre M, Crane C, Pun S . Progress on Modulating Tumor-Associated Macrophages with Biomaterials. Adv Mater. 2019; 32(13):e1902007. PMC: 7098849. DOI: 10.1002/adma.201902007. View

16.

Di Martile M, Farini V, Consonni F, Trisciuoglio D, Desideri M, Valentini E . Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages. J Immunother Cancer. 2020; 8(1). PMC: 7254128. DOI: 10.1136/jitc-2019-000489. View

17.

Wang Z, Zhao Y, Xu H, Liang F, Zou Q, Wang C . CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer. J Cell Mol Med. 2020; 24(19):11445-11456. PMC: 7576280. DOI: 10.1111/jcmm.15751. View

18.

Arnold J, Magiera L, Kraman M, Fearon D . Tumoral immune suppression by macrophages expressing fibroblast activation protein-α and heme oxygenase-1. Cancer Immunol Res. 2014; 2(2):121-6. PMC: 4007628. DOI: 10.1158/2326-6066.CIR-13-0150. View

19.

McAllister F, Wadud Khan M, Helmink B, Wargo J . The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond. Cancer Cell. 2020; 36(6):577-579. DOI: 10.1016/j.ccell.2019.11.004. View

20.

Bohn T, Rapp S, Luther N, Klein M, Bruehl T, Kojima N . Tumor immunoevasion via acidosis-dependent induction of regulatory tumor-associated macrophages. Nat Immunol. 2018; 19(12):1319-1329. DOI: 10.1038/s41590-018-0226-8. View